Quarterly report pursuant to Section 13 or 15(d)

Organization, Plan of Business Operations (Details)

v3.22.1
Organization, Plan of Business Operations (Details)
$ in Thousands
Mar. 31, 2022
USD ($)
Feb. 15, 2022
Vote
Dec. 31, 2021
USD ($)
Accumulated deficit | $ $ 79,860   $ 76,999
Cash and cash equivalents | $ $ 1,833   $ 3,763
Number of no votes | Vote   14  
Invagen Pharmaceuticals Inc      
Number of yes votes | Vote   8